NCT05434936

Brief Summary

This study will compare efficacy of ovarian tissue freezing using slow-freeze versus vitrification methods.

Trial Health

53
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial recruitment is currently suspended
Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
18mo left

Started Aug 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress86%
Aug 2017Oct 2027

Study Start

First participant enrolled

August 11, 2017

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 20, 2017

Completed
4.7 years until next milestone

First Posted

Study publicly available on registry

June 28, 2022

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 10, 2025

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 10, 2027

Expected
Last Updated

June 18, 2023

Status Verified

June 1, 2023

Enrollment Period

8.2 years

First QC Date

October 20, 2017

Last Update Submit

June 14, 2023

Conditions

Keywords

oncofertility

Outcome Measures

Primary Outcomes (1)

  • Effect of vitrification and slow freeze cryopreservation methods on follicular survival

    Investigators will explore and compare the impact of vitrification and slow freeze cryopreservation methods by evaluating follicular survival using classic histological analysis of follicular morphology.

    5+ years

Secondary Outcomes (1)

  • Live birth rates in patients using cryopreserved ovarian tissue

    5+ years

Study Arms (1)

Collection

OTHER

There is only one arm of the study, all patients enrolled will have surgery in which the attempt will be made to collect ovarian tissue.

Procedure: Oophorectomy

Interventions

OophorectomyPROCEDURE

Patients undergoing surgery for any indicated procedure for fertility-threatening treatment will have attempt at collecting ovarian tissue at time of surgery.

Collection

Eligibility Criteria

Age0 Years - 42 Years
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Female Patients only
  • years of age.
  • Will undergo surgery, chemotherapy, drug treatment and/or radiation for the treatment or prevention of a medical condition or malignancy that places the patient at risk for impaired ovarian function and infertility OR, have a medical condition or malignancy that requires removal of all or part of one or both ovaries.
  • May have newly diagnosed or recurrent disease. Those not enrolled at the time of initial diagnosis are eligible if they have not received therapy that is viewed as likely to result in complete and permanent loss of ovarian function.
  • Signed an approved informed consent and authorization permitting the release of personal health information. The patient and/or the patient's legally authorized guardian(s) must acknowledge in writing that consent for specimen collection has been obtained, in accordance with institutional policies approved by the U.S. Department of Health and Human Services.

You may not qualify if:

  • Girls and women with psychological, psychiatric, or other conditions which prevent giving informed consent.
  • Girls and women whose underlying medical condition significantly increases their risk of complications from anesthesia and surgery.
  • Girls and women who are permanently menopausal, as documented by history and FSH levels.
  • Girls and women who are pregnant.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Texas Children's Hospital Pavilion For Women

Houston, Texas, 77030, United States

Location

MeSH Terms

Interventions

Ovariectomy

Intervention Hierarchy (Ancestors)

CastrationEndocrine Surgical ProceduresSurgical Procedures, OperativeUrogenital Surgical ProceduresGynecologic Surgical Procedures

Study Officials

  • Terri L Woodard, MD

    Baylor College of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: This is a tissue bank protocol in which prospectively collected specimens of ovarian tissue and a sample of whole blood will be obtained from patients who elective to cryopreserve ovarian tissue to preserve fertility. The portion of tissue designated for patient use will be cryopreserved using the slow freeze method while the portion designated for research purposed will be divided and cryopreserved using the slow freeze versus vitrification methods.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

October 20, 2017

First Posted

June 28, 2022

Study Start

August 11, 2017

Primary Completion

October 10, 2025

Study Completion (Estimated)

October 10, 2027

Last Updated

June 18, 2023

Record last verified: 2023-06

Locations